| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |